Focus on Interferon Signature in Cutaneous Lupus Erythematosus: Novel Therapies From Better Understanding of the Pathogenesis. [PDF]
Gao M, Zhang N, Xia Y.
europepmc +1 more source
Oral Deucravacitinib for Treatment-Refractory Cutaneous Lupus Erythematosus. [PDF]
Matthew EJ, Verma KK, Paulger B.
europepmc +1 more source
Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report. [PDF]
Zhang C +6 more
europepmc +1 more source
Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature. [PDF]
Loricera J +11 more
europepmc +1 more source
Gut dysbiosis in a murine model of cutaneous lupus erythematosus correlates with antigen-specific T cells and antigen-presenting cells in skin. [PDF]
Neff HA +6 more
europepmc +1 more source
Nivolumab-induced subacute cutaneous lupus erythematosus in a patient with sigmoid colon cancer: a case report and review of the literature. [PDF]
Chang L +4 more
europepmc +1 more source
Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus following pembrolizumab therapy. [PDF]
Marchionni E +4 more
europepmc +1 more source
Orchestration of Skin Pathology in Cutaneous Lupus Erythematosus by HLA Class I Down-Regulated Senescent Epidermal Basal Cells. [PDF]
Yamamoto S +13 more
europepmc +1 more source
Positive Direct Immunofluorescence in Rowell Syndrome: Further Support for a Subtype of Cutaneous Lupus Erythematosus. [PDF]
Bissenas A +3 more
europepmc +1 more source

